Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder

Completed · Phase 3

Conditions studied: Major Depressive Disorder

In brief

This study is to evaluate that (SEROQUEL®) quetiapine sustained-release is efficacious and safe in the treatment of patients with MDD.

Key facts

Study ID

NCT00321490

Run by

AstraZeneca

People needed

600

Starts

2006-04-01

Expected to finish

2007-05-01

Last updated by the study team

2009-03-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient has a documented clinical diagnosis of Major Depressive Disorder.
• Be able to understand and comply with the requirements of the study.
• Able to understand and provide written informed consent

You may not qualify if…

• Patients (female) must not be pregnant or lactating
• Current or past diagnosis of stroke or transient ischemic attack (TIA).

Where it is running

• Research Site — Birmingham, Alabama, United States
• Research Site — Scottsdale, Arizona, United States
• Research Site — Beverly Hills, California, United States
• Research Site — San Diego, California, United States
• Research Site — Sherman Oaks, California, United States
• Research Site — Wildomar, California, United States
• Research Site — Boca Raton, Florida, United States
• Research Site — Bradenton, Florida, United States
• Research Site — Jacksonville, Florida, United States
• Research Site — Orlando, Florida, United States
• Research Site — Tampa, Florida, United States
• Research Site — West Palm Beach, Florida, United States
• Research Site — Edwardsville, Illinois, United States
• Research Site — Lake Charles, Louisiana, United States
• Research Site — Baltimore, Maryland, United States
• Research Site — Haverhill, Massachusetts, United States
• Research Site — Okemos, Michigan, United States
• Research Site — Saint Paul, Minnesota, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Princeton, New Jersey, United States
• Research Site — Albuquerque, New Mexico, United States
• Research Site — New York, New York, United States
• Research Site — Dayton, Ohio, United States
• Research Site — Mayfield Village, Ohio, United States
• Research Site — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.